Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
762.95-
QQQ
709.551.01%
BTC/USD
77903.120.8377%
DIA
528.520.57%
GLD
401.741.64%
TLT
81.820.47%

ClearPoint Neuro Inc

CLPTNASDAQ
Trade with Public
Trade with Public
$15.14
-0.41-2.64%
At close: Aug 28, 5:00 PM EST
$15.34
-0.21-1.35%
Pre-Market: 7:00 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

ClearPoint Neuro Analyst Price Targets

Wall Street analyst price targets and consensus rating for ClearPoint Neuro (CLPT).

Price Target Range — 8 Quarters

Analyst Consensus — 3 Analysts

3Buy
Consensus RatingBuy# Analysts3Avg. Consensus PT$26Upside to Avg. PT+71.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Jun 18, 2026B. Riley SecuritiesAnderson SchockPT RaiseBuy$20→$30
Mar 18, 2026B. Riley SecuritiesNeil ChatterjiPT RaiseBuy$18→$20
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $30

B. Riley Securities analyst Anderson Schock maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $20 to $30.
Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $20

B. Riley Securities analyst Neil Chatterji maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $18 to $20.
Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

B. Riley Securities analyst Neil Chatterji maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and lowers the price target from $28 to $18.
Benzinga Newsdesk

PRO
Stifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $9

Stifel analyst Mathew Blackman maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $8 to $9.
Benzinga Newsdesk

PRO
Stifel Maintains Buy on ClearPoint Neuro, Raises Price Target to $25

Stifel analyst Mathew Blackman maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $19 to $25.
Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $20

B. Riley Securities analyst Neil Chatterji maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $15 to $20.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved